| 1 |
Li L, Yu C, Huang C, Wu H, Chu C, Liu P, Liu Y. Attenuation of Ventilation-Enhanced Epithelial–Mesenchymal Transition through the Phosphoinositide 3-Kinase-γ in a Murine Bleomycin-Induced Acute Lung Injury Model. IJMS 2023;24:5538. [DOI: 10.3390/ijms24065538] [Reference Citation Analysis]
|
| 2 |
e Silva Malzone JR, Ribeiro AP, de Souza TS, Wilbert DD, Novo NF, Juliano Y. Clinical and Epidemiological Characteristics of Patients with COVID-19 Admitted to the Intensive Care Unit: A Two-Year Retrospective Analysis. Life 2023;13:741. [DOI: 10.3390/life13030741] [Reference Citation Analysis]
|
| 3 |
Quan L, Tan J, Hua L, You X. Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2-sample Mendelian randomization study. Int J Rheum Dis 2023. [PMID: 36890668 DOI: 10.1111/1756-185X.14624] [Reference Citation Analysis]
|
| 4 |
Sanna A, Pellegrino D, Messina E, Siena LM, Baccolini V, D'Antoni L, Landini N, Baiocchi P, Villari P, Catalano C, Panebianco V, Palange P. The Role of Pulmonary Function Testing and Lung Imaging in the Long-Term Follow-Up of Patients with COVID-19 Pneumonia Role of Pulmonary Function Tests and High-Resolution Computed Tomography in Post-COVID-19 Interstitial Lung Disease. Respiration 2023;:1-9. [PMID: 36806049 DOI: 10.1159/000529441] [Reference Citation Analysis]
|
| 5 |
Shmakova AA, Popov VS, Romanov IP, Khabibullin NR, Sabitova NR, Karpukhina AA, Kozhevnikova YA, Kurilina EV, Tsokolaeva ZI, Klimovich PS, Rubina KA, Vassetzky YS, Semina EV. Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19. Int J Mol Sci 2023;24. [PMID: 36674896 DOI: 10.3390/ijms24021382] [Reference Citation Analysis]
|
| 6 |
Hashemian SM, Farhadi T, Varahram M, Velayati AA. Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury. Expert Rev Anti Infect Ther 2023;21:7-14. [PMID: 36440472 DOI: 10.1080/14787210.2023.2153116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Tsai CL, Lai CC, Chen CY, Lee HS. The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 2023;21:77-86. [PMID: 36399686 DOI: 10.1080/14787210.2022.2150165] [Reference Citation Analysis]
|
| 8 |
Teymouri S, Pourbayram Kaleybar S, Hejazian SS, Hejazian SM, Ansarin K, Ardalan M, Zununi Vahed S. The effect of Fingolimod on patients with moderate to severe COVID-19. Pharmacol Res Perspect 2023;11:e01039. [PMID: 36567519 DOI: 10.1002/prp2.1039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
D'Oria M, Gandin I, Riccardo P, Hughes M, Lepidi S, Salton F, Confalonieri P, Confalonieri M, Tavano S, Ruaro B. Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction. Diagnostics (Basel) 2022;13. [PMID: 36611347 DOI: 10.3390/diagnostics13010055] [Reference Citation Analysis]
|
| 10 |
Peng S, Tian Y, Meng L, Fang R, Chang W, Yang Y, Li S, Shen Q, Ni J, Zhu W. The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review. Front Immunol 2022;13:1103020. [PMID: 36618419 DOI: 10.3389/fimmu.2022.1103020] [Reference Citation Analysis]
|
| 11 |
Bellan M, Apostolo D, Albè A, Crevola M, Errica N, Ratano G, Tonello S, Minisini R, D'Onghia D, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, Cappellano G, Casella S, Chiocchetti A, Clivati E, Giordano M, Manfredi M, Patti G, Pinato DJ, Puricelli C, Raineri D, Rolla R, Sainaghi PP, Pirisi M; No-More COVID study group. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study. Front Immunol 2022;13:1038227. [PMID: 36601115 DOI: 10.3389/fimmu.2022.1038227] [Reference Citation Analysis]
|
| 12 |
Śliż D, Wiecha S, Ulaszewska K, Gąsior JS, Lewandowski M, Kasiak PS, Mamcarz A. COVID-19 and athletes: Endurance sport and activity resilience study-CAESAR study. Front Physiol 2022;13:1078763. [PMID: 36589442 DOI: 10.3389/fphys.2022.1078763] [Reference Citation Analysis]
|
| 13 |
Kobusiak-Prokopowicz M, Fułek K, Fułek M, Kaaz K, Mysiak A, Kurpas D, Beszłej JA, Brzecka A, Leszek J. Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19. Cells 2022;11. [PMID: 36497138 DOI: 10.3390/cells11233882] [Reference Citation Analysis]
|
| 14 |
Ali M, Abdullah F, Naveed A, Ahmed SM, Khan AA, Hasan A. Role of circulatory miRNA-21 and associated signaling pathways in the pathogenesis of pulmonary fibrosis among individuals recovered after COVID-19 infection. Human Gene 2022;34:201093. [DOI: 10.1016/j.humgen.2022.201093] [Reference Citation Analysis]
|
| 15 |
Guziejko K, Moniuszko-Malinowska A, Czupryna P, Dubatówka M, Łapińska M, Raczkowski A, Sowa P, Kiszkiel Ł, Minarowski Ł, Moniuszko M, Groth M, Kaminski KA. Assessment of Pulmonary Function Tests in COVID-19 Convalescents Six Months after Infection. J Clin Med 2022;11. [PMID: 36498626 DOI: 10.3390/jcm11237052] [Reference Citation Analysis]
|
| 16 |
Arikan A, Sayan M. Investigation of SARS-CoV-2 Variants and Their Effect on SARS-CoV-2 Monoclonal Antibodies, Convalescent and Vaccine Plasma by a Novel Web Tool. Diagnostics (Basel) 2022;12. [PMID: 36428929 DOI: 10.3390/diagnostics12112869] [Reference Citation Analysis]
|
| 17 |
Hirahata K, Nawa N, Fujiwara T. Characteristics of Long COVID: Cases from the First to the Fifth Wave in Greater Tokyo, Japan. JCM 2022;11:6457. [DOI: 10.3390/jcm11216457] [Reference Citation Analysis]
|
| 18 |
Ruaro B, Matucci Cerinic M, Salton F, Baratella E, Confalonieri M, Hughes M. Editorial: Pulmonary fibrosis: One manifestation, various diseases. Front Pharmacol 2022;13:1027332. [DOI: 10.3389/fphar.2022.1027332] [Reference Citation Analysis]
|
| 19 |
Corsi A, Caroli A, Bonaffini PA, Conti C, Arrigoni A, Mercanzin E, Imeri G, Anelli M, Balbi M, Pace M, Zanoletti A, Capelli M, Di Marco F, Sironi S. Structural and Functional Pulmonary Assessment in Severe COVID-19 Survivors at 12 Months after Discharge. Tomography 2022;8:2588-603. [PMID: 36287815 DOI: 10.3390/tomography8050216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Beyls C, Martin N, Booz T, Viart C, Boisgard S, Daumin C, Crombet M, Epailly J, Huette P, Dupont H, Abou-Arab O, Mahjoub Y. Prognostic value of acute cor pulmonale in COVID-19-related pneumonia: A prospective study. Front Med (Lausanne) 2022;9:824994. [PMID: 36267616 DOI: 10.3389/fmed.2022.824994] [Reference Citation Analysis]
|
| 21 |
Zhao Y, Wang R, Shi F, Wu J, Jiang F, Song Q. Diagnostic Efficacy of CT Examination on Early Detection of Lung Cancer during Pandemic of COVID-19. Diagnostics (Basel) 2022;12. [PMID: 36292005 DOI: 10.3390/diagnostics12102317] [Reference Citation Analysis]
|
| 22 |
Song Y, Liu J, Liu X, Tang J. COVID-19 Infection Segmentation and Severity Assessment Using a Self-Supervised Learning Approach. Diagnostics 2022;12:1805. [DOI: 10.3390/diagnostics12081805] [Reference Citation Analysis]
|
| 23 |
Ivan AP, Odajiu I, Popescu BO, Davidescu EI. COVID-19 Associated Guillain–Barré Syndrome: A Report of Nine New Cases and a Review of the Literature. Medicina 2022;58:977. [DOI: 10.3390/medicina58080977] [Reference Citation Analysis]
|
| 24 |
Bonato M, Peditto P, Landini N, Fraccaro A, Catino C, Cuzzola M, Malacchini N, Savoia F, Roma N, Salasnich M, Turrin M, Zampieri F, Zanardi G, Zeraj F, Rattazzi M, Peta M, Baraldo S, Saetta M, Fusaro M, Morana G, Romagnoli M. Multidimensional 3-Month Follow-Up of Severe COVID-19: Airways beyond the Parenchyma in Symptomatic Patients. JCM 2022;11:4046. [DOI: 10.3390/jcm11144046] [Reference Citation Analysis]
|
| 25 |
Ruaro B, Confalonieri P, Pozzan R, Tavano S, Mondini L, Baratella E, Pagnin A, Lerda S, Geri P, Biolo M, Confalonieri M, Salton F. Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? JCM 2022;11:3577. [DOI: 10.3390/jcm11133577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Becker J, Decker JA, Römmele C, Kahn M, Messmann H, Wehler M, Schwarz F, Kroencke T, Scheurig-muenkler C. Artificial Intelligence-Based Detection of Pneumonia in Chest Radiographs. Diagnostics 2022;12:1465. [DOI: 10.3390/diagnostics12061465] [Reference Citation Analysis]
|
| 27 |
Lionte C, Sorodoc V, Haliga RE, Bologa C, Ceasovschih A, Petris OR, Coman AE, Stoica A, Sirbu O, Puha G, Constantin M, Dumitrescu G, Gorciac V, Chelariu A, Catana AN, Jaba E, Sorodoc L. Inflammatory and Cardiac Biomarkers in Relation with Post-Acute COVID-19 and Mortality: What We Know after Successive Pandemic Waves. Diagnostics 2022;12:1373. [DOI: 10.3390/diagnostics12061373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Salton F, Confalonieri P, Campisciano G, Cifaldi R, Rizzardi C, Generali D, Pozzan R, Tavano S, Bozzi C, Lapadula G, Meduri GU, Confalonieri M, Comar M, Lerda S, Ruaro B. Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS. J Clin Med 2022;11:2951. [PMID: 35683340 DOI: 10.3390/jcm11112951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 29 |
Kermelly SB, Bourbeau J. eHealth in Self-Managing at a Distance Patients with COPD. Life 2022;12:773. [DOI: 10.3390/life12060773] [Reference Citation Analysis]
|
| 30 |
Schaarschmidt BM, Fistera D, Li Y, Konik M, Haubold J, Grueneisen J, Witzke O, Forsting M, Holzner C, Umutlu L. Streamlining Patient Management of Suspected COVID-19 Patients in the Emergency Department: Incorporation of Pulmonary CT Angiography into the Triaging Algorithm. Diagnostics (Basel) 2022;12. [PMID: 35626338 DOI: 10.3390/diagnostics12051183] [Reference Citation Analysis]
|
| 31 |
Baratella E, Ruaro B, Marrocchio C, Poillucci G, Pigato C, Bozzato AM, Salton F, Confalonieri P, Crimi F, Wade B, Quaia E, Cova MA. Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia. Tomography 2022;8:1221-7. [DOI: 10.3390/tomography8030100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). Int Immunopharmacol 2022;105:108536. [PMID: 35074571 DOI: 10.1016/j.intimp.2022.108536] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 33 |
Pelosi P, Tonelli R, Torregiani C, Baratella E, Confalonieri M, Battaglini D, Marchioni A, Confalonieri P, Clini E, Salton F, Ruaro B. Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update. JCM 2022;11:1704. [DOI: 10.3390/jcm11061704] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 34 |
Jagosz M, Guzik W, Moczała Ł, Rydel M, Misiołek H, Białka S. Young convalescent COVID‐19 pneumonia with extensive pneumomediastinum emphysema: Case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 35 |
Cocconcelli E, Bernardinello N, Giraudo C, Castelli G, Giorgino A, Leoni D, Petrarulo S, Ferrari A, Saetta M, Cattelan A, Spagnolo P, Balestro E. Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia. Front Med 2022;8:823600. [DOI: 10.3389/fmed.2021.823600] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 36 |
Borghesi A, Golemi S, Scrimieri A, Nicosia CMC, Zigliani A, Farina D, Maroldi R. Chest X-ray versus chest computed tomography for outcome prediction in hospitalized patients with COVID-19. Radiol Med 2022. [PMID: 35083642 DOI: 10.1007/s11547-022-01456-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Barros CMSS, Freire RS, Frota E, Rezende Santos AG, Farias MEL, Rodrigues MGA, Silva BM, Prado Jeronimo CM, Netto RLA, Silva Borba MG, Baía-da-Silva D, Brito-Sousa JD, Xavier MS, Araújo-Alexandre MA, Sampaio VS, Melo GC, Arêas GT, Hajjar LA, Monteiro WM, Gomes Naveca F, Costa FTM, Val FFA, Lacerda MVG; Metcovid team. Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial. Front Med (Lausanne) 2021;8:758405. [PMID: 34917633 DOI: 10.3389/fmed.2021.758405] [Reference Citation Analysis]
|
| 38 |
Rahman M, Irmler M, Keshavan S, Introna M, Beckers J, Palmberg L, Johanson G, Ganguly K, Upadhyay S. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity. Viruses 2021;13:2537. [PMID: 34960806 DOI: 10.3390/v13122537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Kheyrandish S, Rastgar A, Arab-zozani M, Sarab GA. Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies. Front Med 2021;8. [DOI: 10.3389/fmed.2021.794599] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 40 |
Xia H, Zhang Z, You F. Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection. Viruses 2021;13:2383. [PMID: 34960652 DOI: 10.3390/v13122383] [Reference Citation Analysis]
|
| 41 |
Vianello A, Guarnieri G, Braccioni F, Lococo S, Molena B, Cecchetto A, Giraudo C, Bertagna De Marchi L, Caminati M, Senna G. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med 2021. [PMID: 34783228 DOI: 10.1515/cclm-2021-1021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
